Department of Obstetrics and Gynecology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Department of Gynecology, Otaru General Hospital, Otaru, Japan.
JAMA Netw Open. 2020 May 1;3(5):e204307. doi: 10.1001/jamanetworkopen.2020.4307.
The role of surgery in early-stage cervical cancer has been established, but it is controversial in locally advanced cervical cancer.
To determine whether a radical hysterectomy method with extended removal of paracervical tissue for locally advanced cervical cancer is associated with satisfactory oncological outcomes.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted from January 1, 2002, to December 31, 2011, and participants were patients with cervical cancer at a single tertiary center in Northern Japan. The median follow-up period was 106 months, and none of the patients were lost to follow-up at less than 60 months. Data analyses were performed from July 1, 2017, to December 31, 2018.
Patients underwent radical hysterectomy using the Okabayashi-Kobayashi method. Bilateral nerve preservation was used for stage IB1/IB2 disease and unilateral nerve preservation for stage IIA/IIB if disease extension outside the uterine cervix was 1-sided. Chemotherapy was used as the choice of adjuvant treatment for patients with an intermediate or high risk of recurrence, while some patients chose or were assigned to radiotherapy.
Primary outcomes were the 5-year local control rate and 5-year overall survival rate along with risk factor analysis.
Of 121 consecutive patients, 76 (62.8%) had early-stage cervical cancer in 2008 International Federation of Gynecology and Obstetrics stages IB1 and IIA1 and 45 (37.2%) had locally advanced cervical cancer in stages IB2, IIA2, and IIB. The median (range) age was 42 (26-68) years. Adjuvant radiotherapy was used in 2 patients (3%) with early-stage cervical cancer and 3 (7%) of those with locally advanced cervical cancer. The 5-year local control rates for early-stage cervical cancer and locally advanced cervical cancer were 99% and 87%, respectively. The 5-year overall survival rates for early-stage cervical cancer and locally advanced cervical cancer were 95% and 82%, respectively. Cox regression analysis showed that lymph node metastasis and histology of adeno(squamous)carcinoma were independent risk factors for the overall survival of patients with cervical cancer treated with radical hysterectomy.
The nerve-sparing Okabayashi-Kobayashi radical hysterectomy for locally advanced cervical cancer may provide survival not inferior to radical hysterectomy or radiotherapy in published literature. The applicability of radical hysterectomy with adjuvant chemotherapy for locally advanced cervical cancer needs to be validated by prospective comparative trials.
手术在早期宫颈癌中的作用已经确立,但在局部晚期宫颈癌中仍存在争议。
确定对于局部晚期宫颈癌,采用广泛切除宫旁组织的根治性子宫切除术方法是否与满意的肿瘤学结果相关。
设计、设置和参与者:这是一项回顾性队列研究,于 2002 年 1 月 1 日至 2011 年 12 月 31 日在日本北部的一家单一三级中心进行,参与者为宫颈癌患者。中位随访时间为 106 个月,在随访 60 个月以下时,没有患者失访。数据分析于 2017 年 7 月 1 日至 2018 年 12 月 31 日进行。
患者接受了 Okabayashi-Kobayashi 方法的根治性子宫切除术。对于 2008 年国际妇产科联合会(FIGO)分期 IB1 和 IIA1 的早期宫颈癌,采用双侧神经保留;对于子宫颈外疾病扩展为单侧的 2A/2B 期宫颈癌,采用单侧神经保留。对于复发风险中等或较高的患者,选择或给予辅助化疗,而一些患者选择或被指定接受放疗。
主要结局是 5 年局部控制率和 5 年总生存率,并进行了风险因素分析。
在 121 例连续患者中,76 例(62.8%)为 2008 年 FIGO 分期 IB1 和 IIA1 的早期宫颈癌,45 例(37.2%)为 IB2、IIA2 和 IIB 的局部晚期宫颈癌。中位(范围)年龄为 42(26-68)岁。2 例(3%)早期宫颈癌和 3 例(7%)局部晚期宫颈癌患者接受了辅助放疗。早期宫颈癌和局部晚期宫颈癌的 5 年局部控制率分别为 99%和 87%。早期宫颈癌和局部晚期宫颈癌的 5 年总生存率分别为 95%和 82%。Cox 回归分析显示,淋巴结转移和腺癌(鳞癌)组织学是宫颈癌患者根治性子宫切除术后总生存率的独立危险因素。
对于局部晚期宫颈癌,采用保留神经的 Okabayashi-Kobayashi 根治性子宫切除术可能提供不劣于根治性子宫切除术或放疗的生存结果。对于局部晚期宫颈癌,辅助化疗的根治性子宫切除术的适用性需要前瞻性对照试验来验证。